Cargando…

Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance

Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ult...

Descripción completa

Detalles Bibliográficos
Autores principales: Boice, Emily N., Berard, David, Hernandez Torres, Sofia I., Avital, Guy, Snider, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410168/
https://www.ncbi.nlm.nih.gov/pubmed/36013236
http://dx.doi.org/10.3390/jpm12081287
_version_ 1784775028966948864
author Boice, Emily N.
Berard, David
Hernandez Torres, Sofia I.
Avital, Guy
Snider, Eric J.
author_facet Boice, Emily N.
Berard, David
Hernandez Torres, Sofia I.
Avital, Guy
Snider, Eric J.
author_sort Boice, Emily N.
collection PubMed
description Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ultrasound and robotics are being developed. Here, we present an ex vivo lower-body porcine model as a testing platform for evaluation of vascular devices and compare its features to commercially available platforms. While the commercially available trainers were simpler to set-up and use, the scope of their utility was limited as they were unable to provide realistic anatomic, physiologic, and sonographic properties that were provided by the ex vivo model. However, the ex vivo model was more cumbersome to set-up and use. Overall, both have a place in the development and evaluation pipeline for ACVADs before testing on live animals, thus accelerating product development and translation.
format Online
Article
Text
id pubmed-9410168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94101682022-08-26 Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance Boice, Emily N. Berard, David Hernandez Torres, Sofia I. Avital, Guy Snider, Eric J. J Pers Med Article Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ultrasound and robotics are being developed. Here, we present an ex vivo lower-body porcine model as a testing platform for evaluation of vascular devices and compare its features to commercially available platforms. While the commercially available trainers were simpler to set-up and use, the scope of their utility was limited as they were unable to provide realistic anatomic, physiologic, and sonographic properties that were provided by the ex vivo model. However, the ex vivo model was more cumbersome to set-up and use. Overall, both have a place in the development and evaluation pipeline for ACVADs before testing on live animals, thus accelerating product development and translation. MDPI 2022-08-05 /pmc/articles/PMC9410168/ /pubmed/36013236 http://dx.doi.org/10.3390/jpm12081287 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boice, Emily N.
Berard, David
Hernandez Torres, Sofia I.
Avital, Guy
Snider, Eric J.
Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
title Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
title_full Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
title_fullStr Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
title_full_unstemmed Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
title_short Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance
title_sort development and characterization of an ex vivo testing platform for evaluating automated central vascular access device performance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410168/
https://www.ncbi.nlm.nih.gov/pubmed/36013236
http://dx.doi.org/10.3390/jpm12081287
work_keys_str_mv AT boiceemilyn developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance
AT berarddavid developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance
AT hernandeztorressofiai developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance
AT avitalguy developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance
AT sniderericj developmentandcharacterizationofanexvivotestingplatformforevaluatingautomatedcentralvascularaccessdeviceperformance